Denosumab for glucocorticoid-induced osteoporosis

Reid Ian R.

首页> 外文期刊>Nature reviews. Endocrinology >Denosumab for glucocorticoid-induced osteoporosis

【24h】

Denosumab for glucocorticoid-induced osteoporosis

机译：Denosumab用于糖皮质激素诱导的骨质疏松症

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Osteoporotic fractures are one of the principal adverse effects resulting from the therapeutic use of glucocorticoids. These fractures contribute substantially to morbidity in patients who already have major disabling chronic diseases. The prevention of these fractures is, therefore, a high priority in patients who require glucocorticoids, particularly older patients.

机译：骨质疏松骨折是由糖皮质激素治疗使用引起的主要不良反应之一。这些骨折大大促进了已经具有重大致残慢性疾病的患者的发病率。因此，预防这些骨折是需要糖皮质激素，特别是老年患者的患者的高优先级。

著录项

来源
《Nature reviews. Endocrinology》 |2018年第7期|共2页
作者
Reid Ian R.;
展开▼
作者单位

Univ Auckland Fac Med &

Hlth Sci Auckland New Zealand;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Effects of denosumab versus teriparatide in glucocorticoid-induced osteoporosis patients with prior bisphosphonate treatment [J] . Yasuaki Hirooka, Yuji Nozaki, Asuka Inoue, Bone Reports . 2020,第a期

机译：Denosumab与萜烯酮在糖皮质激素诱导的骨质疏松症患者的先前双膦酸盐治疗的影响
2. Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugs [J] . Iwamoto Naoki, Okamoto Momoko, Tsuji Sosuke, Journal of bone and mineral metabolism . 2019,第3期

机译：DeNosumab对糖皮质激素诱导的骨质疏松症患者有效，无论是否先前的抗骨质疏松药物如何
3. Denosumab: a new treatment option for glucocorticoid-induced osteoporosis [J] . Tsourdi Elena, Hofbauer Lorenz C. The lancet. Diabetes & endocrinology. . 2018,第6期

机译：Denosumab：糖皮质激素诱导的骨质疏松症的新治疗选择
4. Antiresorptive effect of denosumab in the treatment of osteoporosis in patients with rheumatoid arthritis [C] . M. A. Korolev, N. E. Banshchikova, E. A. Letjagina, 2017 International Multi-Conference on Engineering, Computer and Information Sciences . 2017

机译：地诺单抗对类风湿关节炎骨质疏松症的抗吸收作用
5. The Effects of Bisphosphonates on the Development of Glucocorticoid-Induced Osteoporosis in a Mouse Model of Duchenne Muscular Dystrophy. [D] . Yoon, Sung-Hee Seanna. 2015

机译：双膦酸盐对Duchenne肌营养不良症小鼠模型中糖皮质激素诱导的骨质疏松症发展的影响。
6. Effects of denosumab versus teriparatide in glucocorticoid-induced osteoporosis patients with prior bisphosphonate treatment [O] . Yasuaki Hirooka, Yuji Nozaki, Asuka Inoue, 2020

机译：Deaosumab对糖皮质激素诱导骨质疏松症患者的糖尿病患者的效果
7. The comparative efficiency of denosumab treatment in patients with postmenopausal osteoporosis, primary hyperparathyroidism and glucocorticoid-induced osteoporosis in real clinical practice [O] . Liudmila Ya. Rozhinskaya, Sofya A. Gronskaia, Elizaveta O. Mamedova, 2021

机译：实际临床实践中初期骨质疏松症，原发性甲状旁腺功能亢进，原发性甲状旁腺功能亢进，原发性甲状旁腺性和糖皮质激素诱导骨质疏松症的比较效率

Denosumab for glucocorticoid-induced osteoporosis

摘要

著录项

相似文献

相关主题

期刊订阅